Transfemoral transcatheter aortic valve replacement with VitaFlowTM valve for pure native aortic regurgitation in patients with high surgical risk: Rationale and design of a prospective, multicenter, and randomized SEASON-AR trial

Authors:

Abstract
No abstract available
Funding Information
  • Microport Scientific Corporation

This publication has 22 references indexed in Scilit: